Thus, it seems unlikely that ErbB2 expression of injured hepatocytes is conserved in the progression to preneoplastic lesions and HCC but as ErbB2 positivity in HCC seems to be a recent event in tumorigenesis. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.